Lin Lin is the Director of PK/PD & Pharmacometrics at Eli Lilly, a position held since 2024. Previously, Lin served as a Senior/Principal Scientist and Associate Scientific Director in Clinical Pharmacology and Pharmacometrics at Biogen from 2019 to 2022. Lin earned a Ph.D. in Biomedical/Medical Engineering from the University of Minnesota, where they conducted research in systems biology and modeling. Earlier, Lin worked at Tsinghua University as an Undergraduate Research Assistant, collaborating on cardiac resynchronization therapy projects.
This person is not in any teams
This person is not in any offices